Pharmaceutical News and Articles

Comprehensive and up-to-date drug news for both consumers and healthcare professionals.

Parents' Workplace Chemical Exposure Might Influence Child's Autism

WEDNESDAY, Aug. 13, 2025 A child s symptoms of autism might vary according to their parents exposure to workplace chemicals, a new study says. On-the-job chemic

FDA Approves First Drug for Chronic Lung Condition Bronchiectasis

WEDNESDAY, Aug. 13, 2025 For the first time, people with bronchiectasis will have a treatment option. The U.S. Food and Drug Administration (FDA) has approved I

Novartis Ianalumab Phase III Trial Meets Primary Endpoint in ITP, Demonstrating Statistically Significant Improvement in Time to Treatment Failure

Basel, August 12, 2025 Novartis today announced positive top-line results from VAYHIT2, a Phase III trial evaluating ianalumab plus eltrombopag in patients with

Irritable Bowel Syndrome Still Routinely Disrupts Patients' Lives

Irritable bowel syndrome (IBS) symptoms disrupt affected patients personal and professional lives an average of 19 days each month, according to the results of

Lack of Proper Child Passenger Restraints Seen in Majority of Fatal Car Crashes

Nearly 70 percent of U.S. children in car crashes with a fatality are not using proper child passenger restraints, according to a study published online July 31

Conch Blowing Could Be Effective Treatment For Sleep Apnea

TUESDAY, Aug. 12, 2025 Want to ease your sleep apnea and get a better night s sleep Blow through a conch shell, a new pilot clinical trial says. Regularly blowi

New Vaccine May Help Stop Deadly Pancreatic Cancers From Coming Back

TUESDAY, Aug. 12, 2025 A new vaccine aimed at a common cancer gene mutation could help stop aggressive pancreatic cancers from coming back, a small clinical tri

Magnetic Stimulation, TTNS Both Beat Bladder Training Alone in Overactive Bladder

For women with idiopathic overactive bladder (iOAB), both magnetic stimulation (MStim) and transcutaneous tibial nerve stimulation (TTNS) plus bladder training

Public Believes Dermatologic Side Effects From Cancer Treatment Are Common

Most individuals living in underserved communities believe that dermatologic side effects (DSEs) from anticancer therapies (ACTs) occur at high rates, according

GLP-1 Receptor Agonists May Reduce Complications of Diabetic Retinopathy

For individuals with type 2 diabetes (T2D), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with a slightly increased risk for incident di

Popular Keywords